4//SEC Filing
Parker Albert P 4
Accession 0001062993-23-001388
CIK 0001621443other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 5:30 PM ET
Size
4.8 KB
Accession
0001062993-23-001388
Insider Transaction Report
Form 4
Parker Albert P
Chief Legal Officer
Transactions
- Award
Common Stock
2023-01-24+170,000→ 205,000 total
Footnotes (1)
- [F1]The restricted stock award will fully vest in two installments, subject to continued employment with the Company through the applicable vesting date: 1/3 of the restricted stock will vest on February 1, 2024; and 2/3 of the restricted stock will vest on February 1, 2025.
Issuer
Zynerba Pharmaceuticals, Inc.
CIK 0001621443
Entity typeother
Related Parties
1- filerCIK 0001750079
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 5:30 PM ET
- Size
- 4.8 KB